CME
Reconsidering the Algorithm: Treatment-Resistant DME
Host: Durga Borkar, MD, MMCi Host: Christina Y. Weng, MD, MBA The approval of new, more durable treatments is an exciting development for the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME),